Nanopharmaceutical Drugs Market Size to Reach USD 88.74 Billion in 2028 Growing at a CAGR of 7.3%

Emergen Research has published its latest report titled “Nanopharmaceutical Drugs Market, By Type (Liposomes, Polymeric Micelles, Nanoemulsion, Microemulsion, Solid Lipid Nanoparticles, Others), By Application (Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Neurology, Infectious Disease, Others), By Distribution Channel (Hospital Pharmacies, Offline Retail Pharmacies, Online Retail Pharmacies), and By Region, Forecast to 2028”

According to Emergen Research, the global nanopharmaceutical drugs market size was USD 50.32 billion in 2020 and is expected to reach USD 88.74 billion in 2028 and register a revenue CAGR of 7.3% during the forecast period, 2021-2028.

Market Dynamics:

The global nanopharmaceutical drugs market revenue growth is majorly driven by factors such as rising burden of chronic and acute diseases such as cardiovascular disorders, diabetes, cancer, and neurological disorders such as Parkinson’s disease and Alzheimer’s disease;  increasing applications of nanomedicine in disease diagnosis and treatment, and rapid adoption of advanced nanotechnology-based drugs and therapeutics. Nanopharmaceutical drugs are increasingly being used in the prevention and treatment of severe chronic diseases. These drugs are composed of nanomaterials that are characterized by various advanced physiochemical properties.

Some of the key advantages of nanopharmaceutical drugs include maximized bioavailability, lower risk of side-effects, and improved safety and efficacy of drugs. Hence, nanotechnology-based pharmaceutical drugs find increasing applications in clinical trials and are being used to treat diseases such as cancer and HIV-AIDS in adults. Growth of the global nanopharmaceutical drugs market is further driven by growing use of nanomaterials in development of contrast agents, diagnostic devices, and drug delivery vehicles, and increasing applications of nanotechnology in in-vivo imaging for improved image contrast and enhanced diagnosis.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/378

COVID-19 Impact Analysis:

• Social distancing and restrictions severely disrupted businesses and operations
• Lockdowns caused disruptions in transportation and logistics
• Impacted manufacturing activities and mining operations globally
• Took a toll on economy of various countries
• Caused sudden and drastic downturn in economic activity
• Disrupted agriculture, fisheries, dairy, and other sectors
• Caused loss of employment and financial crisis
• Supply impacts were further compounded owing to reduced disposable income
• Emergence of variants  continue to cause concerns and impact normal routines

Solid Lipid Nanoparticles Segment Accounted for Largest Revenue Share in 2020:

Based on type, the global nanopharmaceutical drugs market is segmented into liposomes, polymeric micelles, nanoemulsion, microemulsion, solid lipid nanoparticles, and others. The solid lipid nanoparticles segment held the largest revenue share in the global market in 2020. Solid lipid nanoparticles play a vital role in controlling and targeting the release and delivery of drugs. Moroever, these particles offer several advantages over other drug particles, such as enhanced drug stability, superior biocompatibility, increased drug content, improved scalability, and easy sterilization.

Oncology Segment to Account for Fastest Revenue CAGR over the Forecast Period:

Based on application, the global nanopharmaceutical drugs market is segmented into oncology, cardiovascular/physiology, anti-inflammatory/immunology, neurology, infectious disease, and others. The oncology segment is projected to register the fastest revenue growth rate in the global market over the forecast period. Factors expected to drive revenue growth of this segment are rising prevalence of cancer across the globe, growing awareness of early cancer diagnosis and prevention, and increasing use of nanopharmaceutical drugs in cancer treatment due to advantages such as improved targeting of lesions/tumor cells, faster drug accumulation in specific tissue, lower toxicity levels, and improved cell specificity.

Asia Pacific Market to Account for Fastest Revenue CAGR:

Among regional markets, the Asia Pacific nanopharmaceutical drugs market is expected to register the fastest revenue growth rate in the global market over the forecast period. Key factors contributing to revenue growth of the regional market are rising burden of acute and chronic diseases such as cancer and cardiovascular disorders, rapid adoption of nanomedicine in treatment of cancer, cardiovascular diseases, and other chronic disorders, increasing government investments in development of healthcare infrastructure – particularly in the developing countries including India and China – and presence of major market players in the region.

Buy your Exclusive copy @ https://www.emergenresearch.com/select-license/378

Major Companies in the Global Nanopharmaceutical Drugs Market Include:

• Amgen Inc.
• AstraZeneca Plc
• Gilead Sciences Inc.
• Novartis AG
• F. Hoffmann-La Roche AG
• AbbVie Inc.
• Johnson & Johnson
• Pfizer Inc.
• Sanofi SA
• Merck & Co. Inc.

For the purpose of this report, Emergen Research has segmented the global nanopharmaceutical drugs market on the basis of type, application, distribution channel, and region:

Type Outlook (Revenue, USD Billion; 2018–2028)

• Liposomes
• Polymeric Micelles
• Nanoemulsion
• Microemulsion
• Solid Lipid Nanoparticles
• Others

Application Outlook (Revenue, USD Billion; 2018–2028)

• Oncology
• Cardiovascular/Physiology
• Anti-inflammatory/Immunology
• Neurology
• Infectious Disease
• Others

Distribution Channel Outlook (Revenue, USD Billion; 2018–2028)

• Hospital Pharmacies
• Offline Retail Pharmacies
• Online Retail Pharmacies

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/nanopharmaceutical-drugs-market

By Region (Revenue, USD Billion; 2018–2028)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • BENELUX
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • U.A.E.
  • South Africa
  • Turkey
  • Rest of Middle East & Africa

Explore Related Reports by Emergen Research:

The global clinical trial software market size reached USD 900.3 Million in 2020 and is expected to reach USD 2,862.0 Million in 2028 registering a CAGR of 15.6%. CTMS industry report classifies global market by share, trend, growth and on the basis of deployment, delivery, end-use, and region.

The global CRISPR/CAS 9 technology market size is expected to reach USD 6,221 Million in 2028 and registering a CAGR of 20.4%. CRISPR-CAS 9 Technology industry report classifies global market by share, trend, growth and on the basis of product & service, application, end-use, and region.

The global AI-based clinical trials solution provider market size reached USD 1.24 Billion in 2020 and is expected to reach USD 5.86 Billion in 2028 registering a CAGR of 21.5%. Artificial Intelligence based Clinical Trials Solution Provider industry report classifies global market by share, trend, growth and on the basis of clinical trial phase, therapeutic application, end-use, and region.

The global functional ingredients market size reached USD 67.94 Billion in 2020 and is expected to reach USD 109.22 Billion in 2028 registering a CAGR of 6.3%. Functional ingredients industry report classifies global market by share, trend, growth and on the basis of product, source, application, and region.

The global emulsifiers market size was USD 7.99 Billion in 2020 and is expected to reach USD 13.08 Billion in 2028 registering a CAGR of 6.3%. Emulsifiers industry report classifies global market by share, trend, growth and on the basis of product type, distribution channel, industry vertical, and region.

The global personalized therapy biosimulation market size reached USD 1,061.7 Million in 2020 and is expected to reach USD 3,164.1 Million in 2028 registering a CAGR of 14.6%. Personalized therapy biosimulation industry report classifies global market by share, trend, growth and on the basis of product, therapeutic area, application, end-use, and region.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-nanopharmaceutical-drugs-market